C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2681928
The invention pertains to certain genetic variants on Chr2q14, Chr2q35 and Chr16q12 as susceptibility variants of breast cancer. Methods of risk assessment and diagnosis of increased and/or decreased susceptibility to breast cancer, using such variants are described. The invention further relates to kits for diagnosing a susceptibility to breast cancer.
L'invention concerne certains variants génétiques du Chr2q14, Chr2q35 et Chr16q12 en tant que variants de sensibilité du cancer du sein. L'invention concerne des procédés d'évaluation et de diagnostic du risque d'une sensibilité augmentée et/ou diminuée au cancer du sein, à l'aide de tels variants. L'invention concerne en outre des coffrets pour diagnostiquer une sensibilité au cancer du sein.
Manolescu Andrei
Stacey Simon
Sulem Patrick
Decode Genetics Ehf.
Ridout & Maybee Llp
LandOfFree
Genetic variants on chr2 and chr16 as markers for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic variants on chr2 and chr16 as markers for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic variants on chr2 and chr16 as markers for use in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1404284